An improved surgical device is disclosed herein. The improved surgical device includes a delivery device and a sealed container. The sealed contained is prepositioned internal to the delivery device and includes an antimicrobial solution. The improved surgical device is configured for inserting an implant into a surgical site. In some embodiments, the sealed container is configured to be manually broken to release the antimicrobial solution prior to inserting the implant into the delivery device. In other embodiments, the sealed container is configured to be automatically broken to release the antimicrobial solution prior to inserting the implant into the delivery device.

The present disclosure relates to a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, and the present disclosure is for providing a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, wherein the haemostatic composition can be used directly on the wound site when bleeding occurs in the surgical area such as surgical operation, trauma, etc. so that hemostasis can be effectively performed, the haemostatic composition can perform wound sealing, tissue repairing promotion, wound surface tissue protection, infection prevention, etc., the haemostatic composition is contained in haemostatic products such as gauze (cotton yarn), sponge, etc. to accelerate the hemostasis speed of the bleeding site and enable rapid hemostasis to be able to shorten the hemostasis time at the same time.

The present disclosure relates to wound dressings that support the cells in the wound area for the treatment of chronic wounds and eliminates the risk of infection development in open wounds. Specifically disclosed is a wound dressing material that includes graphene-based 2,3 dialdehyde bacterial cellulose. Additionally disclosed is a method for preparing the graphene-doped bacterial cellulose wound dressing material.

The present invention relates to an antimicrobial hydrogel wound dressing composition comprising an electro-activated superoxidised solution comprising hypochlorous acid, sodium hypochlorite, and sodium chloride, and also sodium hyaluronate. The present invention also provides a use for said wound dressing composition for acute and chronic wounds, as well as method of preparation for making the same.

Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

A formulation of a discrete liquid patch for the treatment of cold sores or viral lesions, including a combination of the adhesive layer and an active compound/ingredient such as antiviral agents, and/or amino acids, and/or minerals/vitamins. The adhesive layer of the discrete patch is substantially free of hydrocolloid particles. The adhesive layer does not include any backing layer to maintain the compliance of the patch with a thickness ranging from 5 microns to 1,300 microns. Wherein, the discrete patch of the invention is configured to apply to a viral lesion to maintain in contact therewith for a time effective to substantially complete re-epithelialization of the lesion.

The invention relates to a hemostatic composition comprising a mixture of cellulose-based short and long fibers, preparation and use thereof.

In one aspect, a composition for sustained release of oxygen to a tissue is disclosed that includes at least one core-shell oxygen release microsphere (ORM), wherein the core includes a water-soluble polymer-reactive oxygen species (ROS) complex and the shell includes a biodegradable polymer conjugated to a ROS-scavenging enzyme. In some aspects, the reactive oxygen species includes hydrogen peroxide (H.sub.2O.sub.2), the ROS-scavenging enzyme includes catalase, the water-soluble polymer includes polyvinylpyrrolidone (PVP), and the biodegradable polymer includes poly(N-isopropylacrylamide-co-2-hydroxyethyl methacrylate-co-acrylate-oligolactide-co-Nacryloxysuccinimide)[poly(NIPAAm-co-HEMA-co-AOLA-co-NAS)].

A gel is to be disclosed, in particular for use in a wound treatment composition, with which a particularly high storage stability and long-term stability can be achieved with high microbiocidal activity. For this purpose, the gel according to the invention comprises an inorganic silicate as thickener and an electrochemically activated starting saline solution which has a free chlorine content of more than 300 mg/l. In addition, a colored gel having the properties described above can be obtained by adding suitable pigments.

The present invention relates, in part, to hydrophobically-modified polymers and foams and their use in the control of bleeding.